secwatch.observer — SEC 8-K summary
======================================

Issuer:     Envoy Medical, Inc. (COCH)
CIK:        0001840877
Form:       8-K
Filed at:   2025-03-31T23:59:59+00:00
Accession:  0001213900-25-025827
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Envoy Medical FY2024 revenue down $91K; clinical trial enrollment advances
--------------------------------------------------------------------------

- Net revenues decreased $91K YoY; cash and equivalents were $5.5M as of Dec 31, 2024.
- R&D expenses increased $1.2M driven by headcount for Acclaim cochlear implant pivotal study.
- FDA approved pivotal trial; 6 of 10 planned first-stage participants enrolled and implanted.
- New CPT codes for fully implanted middle ear implants effective July 2025; Hearing Device Coverage Clarification Act reintroduced.
- G&A expenses down $438K reflecting lower professional fees post-business combination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840877/000121390025025827/0001213900-25-025827-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840877/000121390025025827/ea0236135-8k_envoy.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-025827

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer